Regina DelBaugh, DO

Transfusion Medicine

Regina DelBaugh, DOCo-Associate Director of Transfusion Medicine; Co-Associate Director of Apheresis

Department: Pathology

Phone: (804) 628-2576

Email: regina.delbaugh@vcuhealth.org

Dr. Regina DelBaugh, DO, MS, earned a Master of Science in Biomedical Sciences and Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine. She completed her residency in Anatomic and Clinical Pathology and Fellowship in Transfusion Medicine at Dartmouth Health.


Contact Dr. DelBaugh for a full CV

Print/Download Dr. DelBaugh Web CV (pdf)

Dr. Regina DelBaugh abbreviated CV  

Education

Postgraduate Medical Training

2023 - 2024 Fellowship

Transfusion Medicine

Dartmouth Health

Lebanon, NH

2019 - 2023 Residency

Anatomic and Clinical Pathology

Dartmouth Health

Lebanon, NH

Medical Education

2015 – 2019 D.O. Philadelphia College of Osteopathic Medicine

Philadelphia, PA

Graduate Education

2011 – 2013 M.S. Philadelphia College of Osteopathic Medicine

Philadelphia, PA

Undergraduate Education

2007 – 2011 B.S. Saint Joseph’s University

Philadelphia, PA

Licenses & Certifications                   

Blood Banking/Transfusion Medicine, American Board of Pathology, 2024

Virginia Medical License

Anatomic and Clinical Pathology, American Board of Pathology, 2023

Selected Awards & Honors

Martha and Michael J. Avallone Endowed Memorial Scholarship

Philadelphia College of Osteopathic Medicine Alumni Scholarship              

Philadelphia College of Osteopathic Medicine Foundation Scholarship       

Philadelphia College of Osteopathic Medicine Board of Trustees Scholarship

Saint Joseph’s University Presidential Scholarship          
              

Editorial Advisory Boards

Ad hoc Reviewer:  

2021 – present     Vox Sanguinis

2021 – present     Journal of Clinical Apheresis

2023 – present     Plasmatology                                                                                                                                                

Professional Service (outside)

2025 – present Cell Therapy Subcommittee, Clinical Applications Committee, Committee Member American Society for Apheresis (ASFA) 

2025 – present Clinical Applications Committee, Committee Member American Society for Apheresis (ASFA)

2024 – present American Society for Apheresis (ASFA)

2024 – present  Donor Health and Safety Committee, Association for the Advancement of Blood and Biotherapies (AABB)

2023 – present  International Society of Blood Transfusion (ISBT)

2021 – present   Association for the Advancement of Blood & Biotherapies (AABB)

2020 – present   American Society for Clinical Pathology (ASCP)    

2020 – present    Association for Molecular Pathology (AMP)           

2020 – present   Accredited Laboratory Inspector, College of American Pathologists (CAP)

2019 – present  Alumni volunteer with PCOM Pillars, Philadelphia College of Osteopathic Medicine (PCOM)                              

2019 – present  College of American Pathologists (CAP)                                                       

Selected Publications

Peer Reviewed Papers

DelBaugh RM, Murphy MF, Staves J, Fachini RM, Wendel S, Hands K, Bonet-Bub C, Kutner JM, Cohn CS, Cox CA, Jacquot C, Hasan RA, Lu W, Juskewitch JE, Raval JS, Rollins-Raval MA, Fung MK, Ziman A, Fermon EJ, Gorlin JB, Peters J, Dunbar NM; BEST foRmation of Anti‐D After Rhogam (RADAR) Study Investigators and the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Why do people still make anti-D over 50 years after the introduction of Rho(D) immune globulin? A Biomedical Excellence for Safer Transfusion (BEST) Collaborative study. Transfusion. 2025 May;65(5):957-967. doi: 10.1111/trf.18202. Epub 2025 Mar 10. PMID: 40059673.

DelBaugh RM, Thomas B, Gower BJ, Condict B, Luitel A, Davis KN, Szczepiorkowski ZM, Kaufman RM, Dunbar NM. Double trouble: A baby with concurrent hemolytic disease of the fetus and newborn and neonatal alloimmune thrombocytopenia. Transfusion. 2025 Jan 4. doi: 10.1111/trf.18120. Epub ahead of print. PMID: 39754478.

DelBaugh RM, Kerr DA, Dominguez-Konicki L, et al. Metastatic Neuroendocrine Neoplasms to the Pancreas: Two Unusual Cases and a Review of the Literature. International Journal of Surgical Pathology. 2023;0(0). doi:10.1177/10668969231185067

Toland, Maris MD; Bentz, Jessica MD; Bonasia, Kyra MD; Damiano, Ella MD; DelBaugh, Regina DO; Gerjevic, Kristen MD. Uterine and Ovarian Histopathology in Transmasculine and Nonbinary Patients on Testosterone Compared to Cisgender Control Patients [ID: 1381367]. Obstetrics & Gynecology 141(5S):p 5S, May 2023. DOI: 10.1097/01.AOG.0000929752.88321.bf

DelBaugh RM, Cook LJ, Siegel CA, Tsongalis GJ, Khan WA. Validation of a rapid HLA-DQA1*05 pharmacogenomics assay to identify at-risk resistance to anti-tumor necrosis factor therapy among patients with inflammatory bowel disease. American Journal of Clinical Pathology, 2023. 

Toland MK, Bonasia K, Bentz J, DelBaugh RM, Vitale EJ, Scudder PN, Damiano EA. Uterine and Ovarian Histopathology after Testosterone for Gender Affirmation: A Systematic Review. Transgender Health. 2023. 

Ondrasik RM, Khan J, Szczepiorkowski ZM, Levy JJ, Dunbar NM. Passive order auditing associated with reductions in red blood cell utilization: National blood shortage experience. Transfusion. 2022;62(8):1551–8. https://doi.org/10.1111/trf.17008

Anderson B, Ondrasik R, Kaur P. Alder-Reilly Anomaly: Morphologic Clue in a Patient with Hunter Syndrome. American Society of Hematology (ASH) Image Bank. Category: Myeloid Disorders > Lysosomal storage disorders. Published Date: 04/20/2022.

Ondrasik RM, Creed C, Anderson SR, Green DC, Houde BE, Godwin KN, Vaickus LJ, Lefferts JA, Khan WA, Tsongalis GJ. Validation of a Rapid PCR-based Assay for BRAF V600 Status for Prognostication and Therapeutic Selection in Colorectal Cancer Patients. J Molec Diagn 2021;23, 1620 (ST24).

Ondrasik RM, Cook LJ, Siegel CA, Tsongalis GJ, Khan WA. Validation of a Rapid HLA-DQA1*05 Pharmacogenomics Assay to Identify At-Risk Resistance to Anti-TNF Therapy in Inflammatory Bowel Disease (IBD) Patients. J Molec Diagn 2021;23, 1572 (G17).

Abstracts

Squyars K, Buscema G, DelBaugh R, Prajapati V, Sanford K. Every Platelet Counts: Reducing Waste with Predictive Inventory Management System. Poster presentation at Association for the Advancement of Blood and Biotherapies (AABB) 2025 Annual Meeting, October 2025.

Williams G, Keller J, Gailliot C, Poklis JL,  Prajapati V, DelBaugh R, Sanford K, Nanco C, Wolf CE. Prevalence of High Phosphatidylethanol (PEth) Concentrations in a Blood Transfusion Product. Poster Presentation at Association for Diagnostics and Laboratory Medicine (ADLM) 2025, July 2025.

DelBaugh RM, Murphy MF, Staves J, Fachini RM, Wendel S, Hands K, Bonet-Bub C, Kutner JM, Cohn CS, Cox CA, Jacquot C, Hasan RA, Lu W, Juskewitch JE, Raval JS, Rollins-Raval MA, Fung MK, Ziman A, Fermon EJ, Gorlin JB, Peters J, Dunbar NM on behalf of the BEST foRmation of Anti D After Rhogam (RADAR) Study Investigators and the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Why Do People Still Make Anti-D Over 50 Years after the Introduction of Rho(D) Immune Globulin? A BEST Collaborative Study. Poster presentation at Association for the Advancement of Blood and Biotherapies (AABB) 2024 Annual Meeting, October 2024.

DelBaugh RM, Main DL, Thomson SL, White CR, Ludwig MR, Szczepiorkowski ZM. What Happened to the Babesia Result? Mobilization Interferes with Babesia Screening Test in Autologous and Allogeneic HPC(A) Donors. Poster presentation at American Society for Apheresis (ASFA) 2024 Annual Meeting, April 2024.

DelBaugh RM, Main DL, Ludwig MR, Szczepiorkowski ZM. True or False: MCV Affects Collection Efficiency of HPC, Apheresis in Autologous Patients. Poster presentation at American Society for Apheresis (ASFA) 2024 Annual Meeting, April 2024.

DelBaugh RM, White CR, Main DL, Kaufman RM, Dunbar NM, Szczepiorkowski ZM. Rapid Response to Therapeutic Plasma Exchange in a Rare Case of Limbic Encephalitis Secondary to Immune Checkpoint Inhibitor Therapy. Poster presentation at American Society for Apheresis (ASFA) 2024 Annual Meeting, April 2024.

Toland MK, Bonasia K, Bentz J, DelBaugh RM, Gerjevic KA, Damiano EA. Uterine and Ovarian Histopathology in Transmasculine and Nonbinary Patients on Testosterone Compared to Cisgender Control Patients. Poster presentation at 2023 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting.

DelBaugh RM, Khan J, Szczepiorkowski ZM, Levy JJ, Dunbar NM. Passive order auditing associated with reductions in red blood cell utilization: National blood shortage experience. Poster presentation at Association for the Advancement of Blood and Biotherapies (AABB) 2022, November 2022.

Toland MK, Bonasia K, Bentz J, DelBaugh RM, Vitale EJ, Scudder PN, Damiano EA. Uterine and Ovarian Histopathological Findings Following Administration of Exogenous Testosterone for Gender Affirmation: A Systematic Review. Oral presentation at World Professional Association for Transgender Health (WPATH) 2022, September 2022.

Ondrasik RM, Creed CI, Anderson SR, Green DC, Houde BE, Godwin KN, Vaickus LJ, Lefferts JA, Khan WA, Tsongalis GJ. Validation of a rapid PCR-based assay for BRAF V600 status for prognostication and therapeutic selection in colorectal cancer patients. J Molec Diagn 2021;23, 1620 (ST24). Poster presentation at Association for Molecular Pathology (AMP) Annual Meeting, Virtual, November 2021.


Print/Download Dr. DelBaugh Web CV  (pdf)

Back to Listing